We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
AVTX | Avalo Therapeutics Inc | 25.32 | 20.57 | 433.05% | 25,364,303 |
XLO | Xilio Therapeutics Inc | 1.44 | 0.801 | 125.35% | 30,040,668 |
NXL | Nexalin Technologies Inc | 1.70 | 0.92 | 117.95% | 9,222,912 |
CERO | CERo Therapeutics Holdings Inc | 2.9181 | 1.29 | 79.02% | 19,847,660 |
BDRX | Biodexa Pharmaceuticals PLC | 1.47 | 0.611 | 71.13% | 85,147,369 |
KYCH | Keyarch Acquisition Corporation | 11.22 | 4.21 | 60.16% | 171,635 |
MESO | Mesoblast Limited | 4.9799 | 1.49 | 42.69% | 12,764,405 |
BFRI | Biofrontera Inc | 1.52 | 0.37 | 32.17% | 206,593 |
OTLK | Outlook Therapeutics Inc | 12.35 | 2.98 | 31.80% | 1,400,276 |
PIK | Kidpik Corporation | 4.30 | 1.03 | 31.50% | 9,166,175 |
IMNN | Imunon Inc | 1.80 | 0.40 | 28.57% | 1,168,678 |
Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301.
SINGAPORE, March 28, 2024 /PRNewswire/ -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, provides a financial and corporate update coincident with the filing of the Company's financial results for the six months ended September 30, 2023. These financial results are for periods prior to the Company's initial public offering ("IPO") in October of 2023.
Kidpik Corp. (NASDAQ: PIK) ("kidpik” or the "Company"), an online clothing subscription-based e-commerce company, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that is has regained full compliance with the Minimum Bid Price Requirement.
TORONTO and GLIL YAM, Israel, March 28, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial and operational results for the year ended December 31, 2023, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of consolidated audited financial statements for the years ended December 31, 2023 and 2022 (the "Annual Financial Statements") and accompanying management's discussion and analysis (the "Annual MD&A") can be accessed by visiting the Company's website at https://investors.imcannabis.com/, and its profile pages ...
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
LWLG | Lightwave Logic Inc | 191 | |
TMSH | TransGlobal Assets Inc | 206 | |
SFRX | Seafarer Exploration Corp | 83 | |
4 | IQST | iQSTEL Inc | 39 |
5 | AMRN | Amarin Corp Plc | 50 |
6 | NB | Niocorp Developments Ltd | 19 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 70,749.10 | 1,284.53 | 1.85% | 1.39T | 5,924,400,454 |
ETH | Ethereum | 3,568.93 | 68.87 | 1.97% | 428.54B | 3,011,796,586 |
USDT | Tether USD | 0.99999 | 0.00055 | 0.06% | 97.83B | 778,178,608 |
BNB | Binance Coin | 581.76 | 7.64 | 1.33% | 91.87B | 420,462,148 |
SOL | Solana | 186.21 | 0.090 | 0.05% | 82.19B | 1,299,865,812 |
STETH | stETH | 3,557.16 | 92.73 | 2.68% | 34.87B | 5,686,979 |
XRP | Ripple | 0.6278 | 0.0163 | 2.67% | 34.31B | 470,233,109 |
DOGE | Dogecoin | 0.22343 | 0.03343 | 17.59% | 31.69B | 2,737,450,589 |
USDC | USD Coin | 0.99997 | -0.00003 | 0.00% | 28.07B | 1,323,830,752 |
ADA | Cardano | 0.6515 | 0.0039 | 0.60% | 22.92B | 153,952,924 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions